(R)-tert-Butyl (1-picolinoylpyrrolidin-3-yl)carbamate

Catalog No. :
ACUKZQ308
CAS No. :
1286207-97-3
Molecular Formula :
C15H21N3O3
Molecular Weight :
291.35

IUPAC Name:tert-butyl (R)-(1-picolinoylpyrrolidin-3-yl)carbamate

(R)-tert-Butyl (1-picolinoylpyrrolidin-3-yl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$312.00Login to see priceInquiryInquiry
250mg95%$507.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-tert-Butyl (1-picolinoylpyrrolidin-3-yl)carbamate
IUPAC Nametert-butyl (R)-(1-picolinoylpyrrolidin-3-yl)carbamate
MDL No.MFCD18378099
Molecular FormulaC15H21N3O3
Molecular Weight291.35
SMILESO=C(OC(C)(C)C)N[C@H]1CN(C(C2=NC=CC=C2)=O)CC1
InChI KeyMBJCFXJUIZBDCR-LLVKDONJSA-N
Synonym(R)-tert-Butyl 1-picolinoylpyrrolidin-3-ylcarbamate;Carbamic acid, N-[(3R)-1-(2-pyridinylcarbonyl)-3-pyrrolidinyl]-, 1,1-dimethylethyl ester
CAS No.1286207-97-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACUKZQ308 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBZXE159 route compound structure diagram
    ACBZXE1591416450-63-9 In Stock
  2. Plus
  3. ACGQAF842 route compound structure diagram
    ACGQAF84214783-00-7 In Stock
  4. Then
  5. ACUKZQ308 route product structure diagram
    ACUKZQ3081286207-97-3
Inquiry

2. ACUKZQ308 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBZXE159 route compound structure diagram
    ACBZXE1591416450-63-9 In Stock
  2. Plus
  3. ACEYNH492 route compound structure diagram
    ACEYNH49239901-94-5 In Stock
  4. Then
  5. ACUKZQ308 route product structure diagram
    ACUKZQ3081286207-97-3
Inquiry

Comments (0)